Mantle cell lymphoma is a rare and aggressive type of non-Hodgkin lymphoma originating from B-cells in the "mantle zone" of the lymph nodes. The development of novel targeted therapies and ...
Shares of AbbVie Inc. ABBV inched 0.35% higher to $193.62 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 1.70% to 5,713.64 ...
Archon Perry Siatis is a FOUNDER of the Ecumenical Patriarch Bartholomew Foundation. In addition to serving as Vice Chair of the Archon Youth Participation Activities Committee, he is also a founding ...
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013.
Eli Lilly is the clear frontrunner to be the largest pharmaceutical stock in 2034. See what its prospects are for the next ...
Healthcare is undervalued despite being a top sector for earnings growth. Read more on attractive investments among ...
Instead of four equal quarterly distributions, AstraZeneca insists on two payments per year, with a greater portion announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback